Article L5121-33 of the French Public Health Code
I. – Except in cases of force majeure, in the event of a stock shortage of a medicinal product of major therapeutic interest for which a stock shortage or risk of a stock shortage presents a serious and immediate risk for patients, or of a vaccine mentioned in the second paragraph of article L. 5121-31, and where neither the medicinal product alternatives that may be available on national territory nor…